Advanced Training in Urologic Oncology

泌尿肿瘤学高级培训

基本信息

项目摘要

DESCRIPTION (provided by applicant): Urologic cancers impose a significant burden on the health of Americans. In 2012, an estimated 58,000 individuals will die from cancers that fall under an urologist's care, a figure that accounts for close to 10% of all cancer mortality. Given the general propensity for urologic cancers to affect older people, these numbers are only expected to rise over the next several decades as the overall population of the United States ages. At the same time, the pace of innovation and discovery in translational science and health services research in the area of cancer continues to accelerate. These combined factors require a well prepared research oriented work force that is capable of asking and answering clinically relevant scientific questions that have potential to be translated into impactful discoveries. Notably, a number of sources suggest that today, only a small fraction of urologic surgeons possess such skills. The primary goal of this T32 application is to prepare urology trainees for an academic career in urologic oncology by providing a comprehensive training program comprised of mentored training options in either translational laboratory science or health services research, based upon trainee interest. Investigative themes of the program will be based on the research focus and expertise of a group of 21 multi-disciplinary externally funded faculty members in the University of Michigan Comprehensive Cancer Center composed of individuals from the Departments of Urology, Internal Medicine, Radiation Oncology, Pathology, Surgery, Human Genetics, and Pharmacology- all in the University of Michigan Medical School as well as faculty from the University of Michigan School of Public Health and the University of Michigan School of Dentistry. This proposal is a new application to train 1-2 fellows per year, on an alternate basis, for 2 years. The major objective of the Urologic Oncology Training Program (UOTP) is to prepare individuals for research and teaching careers in the field of academic Urologic Oncology. Graduating urology residents having an M.D. or M.D./PhD. degree will be eligible. The UOTP is structured around a research project supervised by the mentor and a required core curriculum comprised of specific graduate level courses that may lead to a Masters degree. Following acceptance, each trainee will choose between 1 of 2 tracks: translational laboratory science or health services research. The goals of the program are to ensure that each trainee: 1) design, implement, analyze and report a research project, 2) obtain formal instruction on fundamental research methods and 3) gain instruction on either fundamental principles of cancer biology (translational science track) or essential elements of conducting health services research (health services track). There will be a special emphasis on formulating and testing hypotheses that address clinically important questions. Additional training in the effective communication of scientific results as well as grant preparation will be provided to all trainees. The ultimate goal of the UOTP is to prepare trainees for independent careers in academic urologic oncology.
描述(由申请人提供):泌尿系统癌症给美国人的健康带来了重大负担。 2012 年,估计有 58,000 人将死于泌尿科医生治疗的癌症,这一数字接近所有癌症死亡率的 10%。鉴于泌尿系统癌症普遍影响老年人,预计随着美国总人口老龄化,这些数字在未来几十年内只会上升。与此同时,癌症领域转化科学和健康服务研究的创新和发现步伐不断加快。这些综合因素需要一支准备充分的以研究为导向的工作人员队伍,能够提出和回答临床相关的科学问题,这些问题有可能转化为有影响力的发现。值得注意的是,许多消息来源表明,如今只有一小部分泌尿外科医生拥有此类技能。此 T32 应用程序的主要目标是根据受训者的兴趣,提供全面的培训计划,包括转化实验室科学或健康服务研究方面的指导培训选项,为泌尿科受训者在泌尿肿瘤学领域的学术生涯做好准备。该项目的研究主题将基于密歇根大学综合癌症中心 21 名多学科外部资助教职人员的研究重点和专业知识,这些教职人员来自密歇根大学医学院的泌尿科、内科、放射肿瘤学、病理学、外科、人类遗传学和药理学系以及密歇根大学公共卫生学院和密歇根大学 密歇根牙科学院。该提案是一项新的申请,每年轮流培训 1-2 名研究员,为期 2 年。泌尿肿瘤学培训计划 (UOTP) 的主要目标是为个人在学术泌尿肿瘤学领域的研究和教学生涯做好准备。具有医学博士或医学博士/博士学位的泌尿外科住院医师毕业生。学位将有资格。 UOTP 围绕由导师监督的研究项目和所需的核心课程构建,该课程由可能获得硕士学位的特定研究生水平课程组成。接受后,每位学员将在以下两个方向中选择一个:转化实验室科学或卫生服务研究。该计划的目标是确保每位学员:1)设计、实施、分析和报告研究项目,2)获得基础研究方法的正式指导,3)获得癌症生物学基本原理(转化科学轨道)或进行卫生服务研究基本要素(卫生服务轨道)的指导。将特别强调制定和测试解决临床重要问题的假设。将为所有学员提供有效传播科学成果以及拨款准备方面的额外培训。 UOTP 的最终目标是培养学员在学术泌尿肿瘤学领域的独立职业生涯。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

BRENT K. HOLLENBECK其他文献

BRENT K. HOLLENBECK的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('BRENT K. HOLLENBECK', 18)}}的其他基金

Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
  • 批准号:
    10862259
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
Physician dispensing of oral specialty drugs for advanced prostate cancer and its implications for patients
医生对晚期前列腺癌口服专科药物的配药及其对患者的影响
  • 批准号:
    10560826
  • 财政年份:
    2023
  • 资助金额:
    $ 23.1万
  • 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
  • 批准号:
    10416477
  • 财政年份:
    2022
  • 资助金额:
    $ 23.1万
  • 项目类别:
Aligning financial incentives to promote rational use of active surveillance for prostate cancer
调整财政激励措施以促进前列腺癌主动监测的合理使用
  • 批准号:
    10592422
  • 财政年份:
    2022
  • 资助金额:
    $ 23.1万
  • 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
  • 批准号:
    10432116
  • 财政年份:
    2020
  • 资助金额:
    $ 23.1万
  • 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
  • 批准号:
    10625489
  • 财政年份:
    2020
  • 资助金额:
    $ 23.1万
  • 项目类别:
Accelerating the Shift to Downside Risk in Medicare Accountable Care Organizations: Effects on Clinical Quality and Costs among Older Patients
医疗保险责任医疗组织加速转向下行风险:对老年患者临床质量和成本的影响
  • 批准号:
    10862329
  • 财政年份:
    2020
  • 资助金额:
    $ 23.1万
  • 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
  • 批准号:
    10224611
  • 财政年份:
    2017
  • 资助金额:
    $ 23.1万
  • 项目类别:
Impact of urologist practice organization and health policy on prostate cancer treatment, overtreatment and spending
泌尿科医生执业组织和卫生政策对前列腺癌治疗、过度治疗和支出的影响
  • 批准号:
    9750134
  • 财政年份:
    2017
  • 资助金额:
    $ 23.1万
  • 项目类别:
Accountable care organizations and the diffusion of new surgical procedures
负责任的护理组织和新外科手术的传播
  • 批准号:
    9067196
  • 财政年份:
    2015
  • 资助金额:
    $ 23.1万
  • 项目类别:

相似海外基金

Urologic Oncology Research Training Grant
泌尿肿瘤学研究培训补助金
  • 批准号:
    9749998
  • 财政年份:
    2019
  • 资助金额:
    $ 23.1万
  • 项目类别:
Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
  • 批准号:
    10646219
  • 财政年份:
    2014
  • 资助金额:
    $ 23.1万
  • 项目类别:
Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
  • 批准号:
    10427182
  • 财政年份:
    2014
  • 资助金额:
    $ 23.1万
  • 项目类别:
Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
  • 批准号:
    8740960
  • 财政年份:
    2014
  • 资助金额:
    $ 23.1万
  • 项目类别:
Advanced Training in Urologic Oncology
泌尿肿瘤学高级培训
  • 批准号:
    9793339
  • 财政年份:
    2014
  • 资助金额:
    $ 23.1万
  • 项目类别:
Urologic Oncology Research Training Grant
泌尿肿瘤学研究培训补助金
  • 批准号:
    7235998
  • 财政年份:
    1999
  • 资助金额:
    $ 23.1万
  • 项目类别:
Urologic Oncology Research Training Grant
泌尿肿瘤学研究培训补助金
  • 批准号:
    8299404
  • 财政年份:
    1999
  • 资助金额:
    $ 23.1万
  • 项目类别:
T32 Urologic Oncology Research Training Program
T32 泌尿肿瘤学研究培训计划
  • 批准号:
    10024657
  • 财政年份:
    1999
  • 资助金额:
    $ 23.1万
  • 项目类别:
T32 Urologic Oncology Research Training Program
T32 泌尿肿瘤学研究培训计划
  • 批准号:
    10474284
  • 财政年份:
    1999
  • 资助金额:
    $ 23.1万
  • 项目类别:
Urologic Oncology Research Training Grant
泌尿肿瘤学研究培训补助金
  • 批准号:
    6845175
  • 财政年份:
    1999
  • 资助金额:
    $ 23.1万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了